A micromethod adapted for automated determinations was used to measure basal plasma levels of homocyst(e)ine [H(e)J. These levels included the sum of free and bound forms of homocysteine, its disulfide oxidation product, homocystine, and the homocysteine-cysteinemixed disulfide. Two groups of subjects were studied: apparently healthy individuals (n = 103) and patients with peripheral arterial occlusive disease (PAOD) (n= 47). Because age in PAOD patients was higher than in control subjects, the control subjects were subdivided into younger and older groups (aged 60 years or less and more than 60 years, respectively). The H(e) levels in the younger groups were 11.18±3.58 (mean+SD, expressed as homocysteine) and 8.58 +2.82 nmol/ml in men and women, respectively; in the older groups, the levels were 10.74±2.16 and 9.04+2.16 nmol/ml in men and women, respectively. There was a positive correlation of H(e) levels with age in the younger control women (r=0.373; p <0.02); no significant correlations were present in the other three control groups. Levels of H(e) in PAOD patients (15.44±5.76 and 17.04±8.26 nmol/ml in men and women, respectively) were significantly higher than those indicated above in the older controls. Next, the PAOD patients were assigned to two subgroups: 1) those with normal levels of H(e) (within two standard deviations of the mean of the control values) and 2) those with elevated levels of H(e). Age, cholesterolemia, and the prevalence of smoking and diabetes were similar in both subgroups. These results suggest that elevated plasma H(e) is an independent risk factor for arterial occlusive disease. (Circulation 1989;79:1180-1188 
T he positive correlation existing between hyperlipoproteinemia and atherosclerosis has been firmly established through data derived from numerous epidemiologic and experimental observations' as well as from intervention trials.2,3 Although most of the clinical data have been obtained in relation to coronary heart disease (CHD),4 hyperlipoproteinemia is also observed in patients with peripheral arterial occlusive disease mature acute myocardial infarction and stroke. 8 Moderately elevated basal plasma levels of H(e) (two to five times normal) are observed in certain subjects with CHD who do not exhibit the systemic manifestations of homocystinuric patients.9 Moreover, patients with CHD or with PAOD exhibit higher plasma H(e) levels than control subjects after methionine loading. [10] [11] [12] In the present paper, using a micromethod adapted for automated determinations, we measured basal levels of H(e) in a group of apparently healthy individuals and in patients with PAOD.
Methods

Subjects
Four groups of individuals were studied. Group minations was used to express results by the colorimetric method in all subjects. The presence of cigarette smoking, hypertension, and diabetes was obtained by history. Because all cases were not evaluated by coronary angiography, the presence of CHD was not included in the study. In the combined groups 3 and 4 (n = 47), there was 35 instances of occlusive cerebrovascular disease, 32 instances of lower extremity arterial disease, and 8 instances of abdominal aortic aneurysm (see Table 1 ); there were no cases of evolving stroke or peripheral gangrene. Chromatographic conditions. The mobile phase consisted of 0.1 M monochloroacetic acid and 1.8 mM octylsulfate, pH 3.2, which were filtered through a Millipore glass apparatus equipped with 0.45 gm nylon filter (Schleicher and Schnell, Keene, New Hampshire). The buffer was kept at 370 C in a heating mantle, continuously purged with nitrogen, and maintained under positive pressure to remove dissolved oxygen. The solvent was circulated through the column at a flow of 0.8 ml/min. An Sample preparation. About 
Concentration of Homocyst(e)ine in Plasma
The ages of the control and experimental groups were different (48.0±10.6 years in the apparently healthy individuals, not shown; and 70.1 ± 10.6 years in the PAOD patients, Table 3 ). Consequently, the control groups were subdivided into two subgroups (.60 years and >60 years). In the resulting older groups, ages were similar in control men and the PAOD men, but the PAOD women were slightly older than the corresponding control women.
The concentration of H(e) ( Table 4 ) was 11.18±3.5 and 10.74±2.16 nmol/ml in the younger and older control men, respectively; the levels were 8.58±2.82 and 9.04±2.16 nmol/ml in the younger and older control women, respectively. In both age groups, men had higher levels than women (p<0.05 by Student's t test). As stated, levels of H(e) in PAOD patients were compared only with those levels determined in the older control groups because ages were much closer. The H(e) values were significantly higher in the patients with PAOD, but there were no sex-related differences (15.54±5.76 and 17.04±8.26 nmol/ml in men and women, respectively). These differences remained after H(e) levels, with and without In-transformation, were adjusted to the mean age in the control groups (not shown). The diagram in Figure 3 shows the distribution of H(e) levels in the older controls as well as in the PAOD patients; the diagram demonstrates that 22 out of the 47 Plasma cholesterol levels determined by the colorimetric method were 3.57% higher than by the enzymatic method (not shown); this factor was used for standardization of results in group 2 subjects (see "Methods"). Levels in the younger control subjects and the PAOD patients were similar; older controls had higher plasma cholesterol levels than younger control subjects or PAOD patients (Table  4) ; whether differences were present in high density lipoprotein levels was not determined. The number of control group 1 subjects that smoked (n=9) or had hypertension (n =3) or diabetes (n= 1) was small (not shown), and the respective prevalences were lower than in the PAOD patients (p<0.001, x2, for each contrast, not shown). Moreover, age, levels of plasma cholesterol, and the prevalence of smoking and diabetes were similar in PAOD patients with normal or elevated levels of H(e); in the last subgroup of patients, the presence of hypertension was more frequent (Table 5 ). Discussion The measurement of blood thiol compounds by HPLC coupled with electrochemical detection19 has definite advantages over methods requiring precolumn or postcolumn derivation9'20-23 and has been used by several investigators.18'24-27 The HPLC electrochemical method of Smolin and Schneider, 18 with the minor modifications we have introduced, required small aliquots of plasma and simple preparation of samples, demonstrated adequate sensitivity and specificity, and could be adapted to an automated injection procedure. In our experience, a relatively large number of duplicate determinations could be run daily; differences between plasma and serum were minimal, and values are similar in fasting and nonfasting samples.
Practical considerations prevented the evaluation of control subjects with the invasive and noninvasive methods used in the PAOD patients; however, all control subjects were active, and none had symptoms of PAOD. Thus, the control group is probably representative of a middle-aged working population in apparently good health. Our control values of plasma H(e) were similar to those reported by Brattstrom28 and Stabler et a123 but somewhat higher than those reported previously by Kang et al, 9 Refsum et al,21 and Araki and Sako.22 Such differences are not unusual when blood values are determined by different methods.
Basal plasma levels of H(e) were higher in men than in women; sex differences in the plasma concentration of these sulfur-containing amino acids have been observed previously.9'29 Moreover, Boers et a130 demonstrated that the serum levels of homocysteine-mixed disulfide, before and after methionine loading, were lower in premenopausal women than in older women. Similarly, Kang et a19 showed a positive correlation between basal H(e) levels and age in women. In our analysis of women 60 years of age or younger, which probably included premenopausal and postmenopausal subjects, there was also a significant positive correlation between basal H(e) levels and age; we observed no significant correlation in older women. These results accord with those reported by Boers et a130 and Kang et al. 9 On the other hand, those authors did not find differ- Normal, within 2 SD of mean from older controls (see "Methods"); Elevated, above 2 SD of mean from older controls (see "Methods").
None of the findings are significantly different in patients with normal or elevated plasma H(e) with the exception of H(e) levels (p<O.OOl) and hypertension (p<0.05).
ences in the H(e) levels of younger or older men; we, too, did not detect significant correlations between H(e) levels and age in men. Basal plasma levels of H(e) were elevated in the PAOD patients when values were contrasted with either the younger or older control subjects. Furthermore, H(e) levels adjusted for age were significantly higher in PAOD patients than in control subjects.
The average cholesterolemia was similar in PAOD patients and in younger controls, but it was lower than in the older controls; the significance of this finding is not clear, but it could result from the selection process of subjects or other unidentified factors. Age and the prevalence of hypertension, smoking, and diabetes were higher in PAOD patients than in control subjects, as reported in numerous studies of patients with atherosclerosis. 31 Finally, age, cholesterolemia, and the prevalence of smoking and diabetes were similar in PAOD patients with normal or with elevated levels of H(e), but hypertension was more frequent in patients with high levels of H(e); reasons for this disparity need further study. The overall findings suggest that hyperhomocyst(e)inemia is an independent risk factor for occlusive atherosclerosis; such a conclusion has been advanced by other investigators. [9] [10] [11] [12] 32 There 52) .
The present observations demonstrate the feasibility of using a relatively simple method for measuring basal plasma levels of H(e) and confirm that hyperhomocyst(e)inemia is a common occurrence in patients with PAOD. Moreover, the reports menthe metabolism of methylcobalamin, the coenzyme tioned above suggest that multiple mechanisms may be operative in hyperhomocyst(e)inemia and that this condition is likely to damage vascular endothelium, promote thrombosis, oxidize LDL, and thus influence atherogenesis. Elevated levels of H(e) often decrease toward normal values after the ingestion of small doses of folate53 or other similarly innocuous treatments.8 Whether normalization of hyperhomocyst(e)inemia would favorably alter the evolution of atherosclerosis needs to be established.
